This ELISA kit provides quantitative measurement of high-sensitivity C-reactive protein (hs-CRP) in human samples, targeting the low-grade inflammatory concentrations that standard CRP assays cannot resolve. Because hs-CRP levels in the 1–3 mg/L range carry critical prognostic significance for cardiovascular risk stratification, this kit is designed to discriminate within that clinically meaningful low-concentration window.
Detection Range: The 0.78–50 ng/mL range captures hs-CRP concentrations spanning baseline healthy levels through moderate acute-phase elevations. Since circulating hs-CRP in serum typically falls between 0.5–10 mg/L, samples require dilution on the order of 1:100–1:1000, which should be optimized based on the clinical or experimental context.
Sensitivity: At 0.39 ng/mL, the assay detects hs-CRP at concentrations corresponding to the lowest cardiovascular risk tier (<1 mg/L after dilution correction), enabling differentiation between low-risk and moderate-risk individuals that conventional CRP assays miss entirely.
Sample Compatibility: Validation across serum, plasma, cell culture supernatants, and tissue homogenates supports studies linking systemic hs-CRP levels to localized hepatic production or adipose tissue inflammation, connecting circulating biomarker data with tissue-level mechanistic experiments.
Assay Efficiency: The 1–5 hour protocol using 50–100 µL accommodates both high-throughput cohort screening and smaller mechanistic studies where sample volume from primary hepatocyte cultures is limited.
This kit supports research in cardiovascular risk assessment, metabolic syndrome progression, and chronic low-grade inflammation.